We are live on ! Find out more
CAH icon

Cardinal Health

792 hedge funds and large institutions have $12.2B invested in Cardinal Health in 2022 Q2 according to their latest regulatory filings, with 92 funds opening new positions, 264 increasing their positions, 299 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 67

29% more call options, than puts

Call options by funds: $142M | Put options by funds: $110M

1% more funds holding

Funds holding: 784792 (+8)

0.41% more ownership

Funds ownership: 84.92%85.33% (+0.41%)

8% less capital invested

Capital invested by funds: $13.2B → $12.2B (-$1.06B)

12% less repeat investments, than reductions

Existing positions increased: 264 | Existing positions reduced: 299

36% less funds holding in top 10

Funds holding in top 10: 117 (-4)

Holders
792
Holders Change
+8
Holders Change %
+1.02%
% of All Funds
13.34%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.12%
New
92
Increased
264
Reduced
299
Closed
67
Calls
$142M
Puts
$110M
Net Calls
+$31.7M
Net Calls Change
+$1.11M
Name Holding Trade Value Shares
Change
Change in
Stake
SO
276
STRS Ohio
Ohio
$1.75M -$343K -6,032 -15%
ISB
277
Iowa State Bank
Iowa
$1.69M +$27.3K +481 +2%
BCIM
278
British Columbia Investment Management
British Columbia, Canada
$1.69M -$636K -11,185 -26%
Cambridge Investment Research Advisors
279
Cambridge Investment Research Advisors
Iowa
$1.65M +$167K +2,938 +10%
TC
280
Trilogy Capital
California
$1.64M +$227K +3,996 +15%
NAM
281
Nissay Asset Management
Japan
$1.61M -$61.9K -1,090 -3%
FHA
282
First Horizon Advisors
Tennessee
$1.57M +$211K +3,705 +14%
OIM
283
Orca Investment Management
Oregon
$1.56M -$6.48K -114 -0.4%
USCWA
284
U.S. Capital Wealth Advisors
Texas
$1.55M -$1.99K -35 -0.1%
CAM
285
Cozad Asset Management
Illinois
$1.55M +$26.3K +463 +2%
GIA
286
GHP Investment Advisors
Colorado
$1.53M +$29.6K +521 +2%
VPIM
287
Vanguard Personalized Indexing Management
California
$1.51M +$39.3K +692 +2%
DGAM
288
Desjardins Global Asset Management
Quebec, Canada
$1.48M -$1.56M -27,524 -49%
Mercer Global Advisors
289
Mercer Global Advisors
Colorado
$1.48M +$6.54K +115 +0.4%
X
290
Xponance
Pennsylvania
$1.46M -$564K -9,923 -26%
VanEck Associates
291
VanEck Associates
New York
$1.45M -$426K -7,487 -21%
UCFA
292
United Capital Financial Advisors
Texas
$1.44M -$60.6K -1,066 -4%
Bank of Nova Scotia
293
Bank of Nova Scotia
Ontario, Canada
$1.41M -$512K -9,015 -25%
BA
294
Bridgewater Advisors
New York
$1.41M +$3.69K +65 +0.2%
CCP
295
Cunning Capital Partners
North Carolina
$1.4M +$1.52M +26,800 New
Thrivent Financial for Lutherans
296
Thrivent Financial for Lutherans
Minnesota
$1.39M +$25.1K +442 +2%
VAS
297
Vestmark Advisory Solutions
Massachusetts
$1.39M +$314K +5,526 +26%
Lido Advisors
298
Lido Advisors
California
$1.39M -$65.9K -1,160 -4%
CM
299
Caption Management
Oklahoma
$1.39M +$143K +2,516 +10%
BAM
300
Blueshift Asset Management
New Jersey
$1.39M +$597K +10,507 +66%

CAH Hedge Fund Activity: Q2 2022 in Review

792 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cardinal Health (CAH) for Q2 2022, worth a combined $12.2B — down 8% from $13.2B a quarter earlier.

Buyers outnumbered sellers: 92 funds opened new CAH positions and 67 closed out — a net gain of 25 holders — while 264 added to existing stakes and 299 trimmed.

The largest buyer was Amundi, adding an estimated $257M. The largest seller was T. Rowe Price Associates, cutting an estimated $174M.

  • 792 institutional investors held Cardinal Health (CAH) as of Q2 2022, up from 784 in Q1 2022.
  • Funds reported $12.2B of Cardinal Health stock for Q2 2022, down 8% quarter-over-quarter.
  • 92 funds opened new Cardinal Health positions in Q2 2022 and 67 closed out, a net change of +25 holders.
  • The largest Cardinal Health buyer in Q2 2022 was Amundi, an estimated $257M added.
  • The largest Cardinal Health seller in Q2 2022 was T. Rowe Price Associates, an estimated $174M sold.

Based on aggregated 13F filings for Q2 2022.